Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-24
Original SEC Filing: Click here

---

Webplus: SVA/20200624/6-K/2_EX-99.1/000.htm SEC Original: tm2023320d1_ex99-1.htm
Sinovac Receives Approval from China for its Quadrivalent Influenza Vaccine BEIJING — (BUSINESS WIRE) — Sinovac Biotech Ltd. (“Sinovac” or the “Company”)(Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced the China National Medical Products Administration (or NMPA) issued a product license for its quadrivalent Influenza vaccine (or QIV). two A strains and two B strains, recommended

---

---

Webplus: SVA/20200624/6-K/1/000.htm SEC Original: tm2023320d1_6k.htm

---

Company Info:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2020-06-24CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 15 ZHI TONG ROAD,, ZHONGGUANCUN TECH PARK, CHANGPING DISTR.
BEIJING 102200